Cobicistat
ATC V03AX03 · 9 markets · 63 records
AU 14 records · 2 strengths
- 150 mgtabletEVOTAZEVOTAZ atazanavir/cobicistat 300 mg/150 mg film coated tablets bottle、Genvoya、GENVOYA elvitegravir (150mg), cobicistat (150mg), emtricitabine (200mg) and tenofovir alafenamide (as fumarate) (10mg) fixed dose combination tablets、PREZCOBIX、PREZCOBIX darunavir/cobicistat 800 mg/150 mg film coated tablet bottle、STRIBILD tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottle、Symtuza、SYMTUZA 800/150/200/10 darunavir/cobicistat/emtricitabine/tenofovir alafenamide 800/150/200/10 mg film-coated tablets
Records without a stated strength · 1 EVOTAZ、Genvoya、PREZCOBIX、Stribild、Symtuza
US 9 records · 2 strengths
- 150 mgtabletEVOTAZGenvoya、PREZCOBIX、Stribild、Symtuza、Tybost
- 90 mgtabletPREZCOBIX PED
GB 8 records · 2 strengths
ES 6 records · 1 strengths
- 150 mgtabletEVOTAZGenvoya、Rezolsta 800mg/150mg tablets、Stribild、Symtuza、Tybost
EU 6 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 EVOTAZ、Genvoya、Rezolsta 800mg/150mg tablets、Stribild、Symtuza、Tybost
CA 4 records · 1 strengths
- 150 mgtabletGenvoyaPREZCOBIX、Stribild、Symtuza
TW 3 records · 1 strengths
Records without a stated strength · 1 Genvoya、Prezcobix Flim-Coated Tablets、Symtuza、信澤力膜衣錠、捷扶康 膜衣錠、普澤力膜衣錠
HK 2 records · 1 strengths
Records without a stated strength · 1 PREZCOBIX、Symtuza
| Strength / form / release | US | GB | CA | AU | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|
| 150 mg tablet | EVOTAZ Genvoya PREZCOBIX | EVOTAZ Genvoya Rezolsta 800mg/150mg tablets | Genvoya PREZCOBIX Stribild+1Symtuza | EVOTAZ EVOTAZ atazanavir/cobicistat 300 mg/150 mg film coated tablets bottle Genvoya+6GENVOYA elvitegravir (150mg), cobicistat (150mg), emtricitabine (200mg) and tenofovir alafenamide (as fumarate) (10mg) fixed dose combination tablets PREZCOBIX PREZCOBIX darunavir/cobicistat 800 mg/150 mg film coated tablet bottle STRIBILD tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottle Symtuza SYMTUZA 800/150/200/10 darunavir/cobicistat/emtricitabine/tenofovir alafenamide 800/150/200/10 mg film-coated tablets | EVOTAZ Genvoya Rezolsta 800mg/150mg tablets | |||
| 90 mg tablet | PREZCOBIX PED | Genvoya | ||||||
unknown | EVOTAZ Genvoya PREZCOBIX | PREZCOBIX Symtuza | EVOTAZ Genvoya Rezolsta 800mg/150mg tablets | |||||
tablet | Genvoya Prezcobix Flim-Coated Tablets Symtuza |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in TW and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en TW que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 TW 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 TW 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.